Found: 15
Select item for more details and to access through your institution.
A Role for GDNF and Soluble APP as Biomarkers of Amyotrophic Lateral Sclerosis Pathophysiology.
- Published in:
- Frontiers in Neurology, 2018, p. 1, doi. 10.3389/fneur.2018.00384
- By:
- Publication type:
- Article
Implications of Gliotransmission for the Pharmacotherapy of CNS Disorders.
- Published in:
- CNS Drugs, 2011, v. 25, n. 8, p. 641, doi. 10.2165/11593090-000000000-00000
- By:
- Publication type:
- Article
Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2023, v. 43, n. 9, p. 1601, doi. 10.1177/0271678X231172520
- By:
- Publication type:
- Article
CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 3, p. 510, doi. 10.1007/s00415-017-8730-6
- By:
- Publication type:
- Article
Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 14, p. 3080, doi. 10.1093/hmg/ddw161
- By:
- Publication type:
- Article
The BH4 domain of Bcl-XL rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals.
- Published in:
- Human Molecular Genetics, 2012, v. 21, n. 4, p. 826, doi. 10.1093/hmg/ddr513
- By:
- Publication type:
- Article
The multifaceted role of glial cells in amyotrophic lateral sclerosis.
- Published in:
- Cellular & Molecular Life Sciences, 2014, v. 71, n. 2, p. 287, doi. 10.1007/s00018-013-1429-7
- By:
- Publication type:
- Article
Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 12, p. 1643, doi. 10.3390/cells12121643
- By:
- Publication type:
- Article
Astrocytes: Dissecting Their Diverse Roles in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 11, p. 1450, doi. 10.3390/cells12111450
- By:
- Publication type:
- Article
Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 8, p. 2019, doi. 10.3390/cells10082019
- By:
- Publication type:
- Article
Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 3, p. 518, doi. 10.3390/cells10030518
- By:
- Publication type:
- Article
Exploring Novel Molecular Targets for the Treatment of High-Grade Astrocytomas Using Peptide Therapeutics: An Overview.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 2, p. 490, doi. 10.3390/cells9020490
- By:
- Publication type:
- Article
CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity.
- Published in:
- Nature Neuroscience, 2001, v. 4, n. 7, p. 702, doi. 10.1038/89490
- By:
- Publication type:
- Article
Dysregulation of Astrocytic HMGB1 Signaling in Amyotrophic Lateral Sclerosis.
- Published in:
- Frontiers in Neuroscience, 2018, p. N.PAG, doi. 10.3389/fnins.2018.00622
- By:
- Publication type:
- Article
Withaferin A Inhibits Nuclear Factor-κB-Dependent Pro-Inflammatory and Stress Response Pathways in the Astrocytes.
- Published in:
- Neural Plasticity, 2015, v. 2015, p. 1, doi. 10.1155/2015/381964
- By:
- Publication type:
- Article